Finance
Private credit has become an important source of financing for businesses and an increasingly visible component of institutional portfolios. Its growth has also deepened the links between private lenders and traditional banks. The Bank of England’s reported scrutiny of Barclays illustrates why those connections matter to high-net-worth individuals (HNWIs): risk can sit within complex financial structures, where the classification of an exposure influences how much capital a bank must hold against potential losses. For internationally diversified families, the issue is not whether private credit should be avoided, but whether the risks embedded in their portfolios are being measured and disclosed adequately.
The reported review centres on total return swaps linked to illiquid private credit loans. These derivatives can allow banks to finance exposures associated with private credit while transferring some or all of their economic performance to another counterparty.
The complaint reportedly questioned whether certain positions were appropriately assigned to the trading book rather than the banking book. That distinction matters because regulatory capital treatment depends partly on how an exposure is classified. If an instrument linked to illiquid assets is treated as more readily tradable than its underlying risks justify, the bank could potentially hold less capital than appropriate.
Barclays has defended its approach, stating that its treatment of the relevant transactions complies with regulatory requirements. It has also said its total private credit exposure is approximately £15 billion, with the vast majority held in the banking book. The review should therefore be understood as a question about risk classification and capital treatment, not proof that the bank has misreported its overall exposure.
For private banking clients, the more significant lesson is that exposure to private credit may extend beyond direct investments in private debt funds. Banks can finance fund managers, provide lending facilities, enter derivatives contracts and lend to companies that also borrow from private lenders.
These relationships can create multiple channels through which financial stress travels. A deterioration in borrowers’ ability to repay may reduce loan values, weaken collateral and increase financing pressure. If several institutions depend on the same borrowers, funds or counterparties, apparent diversification may offer less protection than expected.
Clients should therefore map both direct and indirect exposure. Review private credit fund holdings, structured products, leveraged investment vehicles and lending arrangements involving private debt strategies. Where disclosure is limited, establish what information the manager can provide about underlying borrowers, leverage, valuation methods and counterparty concentration.
Private credit is generally less liquid than publicly traded bonds. Derivatives and hedging arrangements may alter the distribution of financial risk, but they do not automatically make the underlying loans easy to sell during market stress.
For HNWIs, this distinction is critical when matching investments to future obligations. Examine redemption restrictions, notice periods, valuation frequency and the circumstances in which withdrawals may be delayed or limited. Compare those terms with capital calls, borrowing commitments, tax liabilities and expected family expenditure.
Reported valuations also deserve scrutiny. Infrequent pricing can make private assets appear more stable than publicly traded securities, even when underlying credit conditions are deteriorating. A smooth valuation history should not be confused with an absence of economic risk.
The Barclays case could encourage regulators to examine how other banks classify and capitalise exposures connected to private credit. Any broader response will depend on the findings of supervisory reviews, rather than the allegations alone.
Swiss-based families should ask their private banks and external managers how they assess private credit counterparties, stress-test liquidity and identify overlapping exposures. For portfolios using leverage, review collateral requirements and the potential consequences of falling asset values or tighter lending conditions.
The objective is not to react to a single investigation, but to ensure that complex structures remain understandable under pressure. For a confidential discussion regarding your private credit exposure, counterparty risk and cross-border wealth structure, contact our senior advisory team.
October 22, 2026
October 21, 2026
October 21, 2026
October 21, 2026
SKN | The FCA’s Whistleblower Feedback Retreat: Why Regulatory Accountability Matters to Global Wealth
SKN | Barclays Faces Heightened Scrutiny Over Private Credit Risk Controls and Regulatory Oversight
SKN | UBS Weighs Its Swiss Future as Tougher Capital Rules Threaten Global Competitiveness